That's standard accrual accounting, not the company.
Sales and other revenue broken down easily enough, and importantly the big one API Sales Revenue:
"Under the terms of the commercialisation agreement with Padagis, Acrux is currently responsible for the procurement of the Active Pharmaceutical Ingredients (‘API’) which are used in the commercial manufacture of Prilocaine 2.5% and Lidocaine 2.5%, Cream. These API purchases are recorded as Cost of Goods Sold and are in turn invoiced to Padagis and are included as Sales Revenue. The increased value of purchases and sales of Prilocaine and Lidocaine API reflect the increase in manufacturing activity relative to the prior comparative period, when the API had been purchased for the manufacture of launch stocks."
- Forums
- ASX - By Stock
- ACR
- Ann: Appendix 4D and Half Year Accounts
Ann: Appendix 4D and Half Year Accounts, page-7
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.9¢ |
Change
-0.002(2.82%) |
Mkt cap ! $20.05M |
Open | High | Low | Value | Volume |
7.5¢ | 7.5¢ | 6.9¢ | $31.16K | 433.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 54422 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 147301 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 54422 | 0.069 |
3 | 224647 | 0.068 |
1 | 30000 | 0.067 |
1 | 7742 | 0.066 |
1 | 50000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 47301 | 1 |
0.073 | 15000 | 2 |
0.075 | 149999 | 1 |
0.077 | 6520 | 1 |
0.080 | 7000 | 1 |
Last trade - 15.53pm 28/06/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online